Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,295,742
+$46,503,892 QoQ
Shares Held
601,019
+44.5% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#29
of 768 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,805,003 | $129,707,515 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
601,019 | $101,295,742 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
134,890 | $73,087,447 | |
| 4 | VTRS |
Viatris Inc
|
3,523,052 | $55,946,065 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,530,206 | $15,898,840 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
732,867 | $7,328,670 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
156,422 | $7,275,186 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
1,451,781 | $7,157,279 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,295,742 | 601,019 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $54,791,850 | 415,909 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,792,513 | 231,210 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,347,196 | 80,832 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,935,834 | 47,226 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,080,792 | 100,188 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,814,886 | 145,164 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $34,125,744 | 296,179 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,108,085 | 233,225 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,963,836 | 289,761 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,956,863 | 318,434 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,630,350 | 334,492 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $59,479,442 | 630,747 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $64,711,969 | 639,320 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $37,739,456 | 315,970 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,225,015 | 105,687 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,772,526 | 28,442 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $23,185,592 | 247,313 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,892,559 | 233,563 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $201,955 | 2,107 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,137,987 | 188,623 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,566,088 | 94,804 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,124,713 | 47,657 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||